Articles

Found results: 16306

Exhibitions and conferences

Nanobiotechnology in promising space experiments

On August 30, 2012, MIPT holds a conference "Living AeroSpace: Nanobiotechnologies in promising space experiments" for researchers, staff of research centers, teachers, graduate students and students.

02.07.2012
Exhibitions and conferences

Synthetic Biology at MIPT

On July 9-12, 2012, MIPT holds a school-conference "Synthetic Biology and design of bioengineering devices" for researchers, researchers, teachers, graduate students and students.

02.07.2012
Genetic engineering

Antibodies of the highest quality

The complex of mutations will increase the stability of therapeutic antibodies and, accordingly, the quality of treatment of many diseases, including oncological and inflammatory.

29.06.2012
Innovative Russia

The best innovators of the year

On June 27, 2012, the solemn ceremony of awarding the winners of the XI Competition of Russian Innovations and the VII Student competition "The best business plan of an innovative project" took place.

29.06.2012
Cellular technologies

How to wean the immune system to destroy beta cells?

It was possible to prevent the development of type 1 diabetes mellitus in mice with a genetic predisposition to this disease with the help of macrophages "weaned" from the destruction of beta cells of the pancreas.

29.06.2012
Biomedicine

A new vaccine against nicotine addiction

One dose of a new gene therapy vaccine for life relieves mice of nicotine addiction, turning their liver into a factory for the production of antibodies against nicotine.

29.06.2012
Cellular technologies

Huntington's disease can be studied "in vitro"

The researchers turned induced pluripotent stem cells into neurons showing signs of Huntington's disease. These cells can be used to test therapies for this currently incurable disease.

28.06.2012
Genetics

The eleventh "parkinsonism gene"

An international group of geneticists and neurologists, as a result of a long-term large-scale study, managed to isolate the last of the mutated genes that provoke the development of Parkinson's disease.

28.06.2012
Note to the businessman

Top 10 pharmaceutical companies in terms of R&D expenses

In 2011, the costs of creating new drugs of the top 10 global pharmaceutical companies in terms of R&D costs amounted to more than $ 70 billion. US$, which is slightly higher than the same indicator in 2010.

28.06.2012
Exhibitions and conferences

RosBioTech-2012

VI International Exhibition "RosBioTech-2012" (7-9 November 2012, Moscow, Expocentre Fairgrounds).

28.06.2012
Various

Another diagnosis of Russian medicine

The healthcare industry of Russia took the second place in the corruption rating of the Russian Federation. Law enforcement agencies are in the first place, education is in the third.

27.06.2012
Genetic engineering

Genetically modified animals are illegal

Pigs with human disease genes are a much better model than rodents, but the FDA has not yet decided whether these animals can be used for experiments.

27.06.2012
Prolonging youth

To grow up to a hundred years ... of sexuality!

A person who regularly lives a sexual life will have sex to the grave. This is normal for a man, unless his health is damaged by alcohol, drugs, some diseases.

27.06.2012
Bioethics

The right to suicide

The European Court of Human Rights will consider two new cases concerning euthanasia and assisted suicide, Koch v. Germany and Alda Gross v. Sweden.

27.06.2012